Evaluating Circulating Tumor DNA to Predict Overall Survival Risk in Non-Squamous Non-Small Cell Lung Cancer in IMpower150 Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Assaf, Z. J.; Fine, A.; Zou, W.; Socinski, M.; Young, A.; Freidin, J.; Kennedy, M.; Polisecki, E.; Nishio, M.; Oxnard, G.; Cummings, C.; Rode, A.; Reck, M.; Patil, N.; Shames, D.; Schulz, K.

authors

Publication Date

  • October 1, 2021

webpage

published in

category

keywords

  • ctDNA variant clearance
  • predictive biomarker
  • surrogate endpoint for survival

start page

  • S905

end page

  • S906

volume

  • 16

issue

  • 10